Bioelectronic cell-based device provides a strategy for the treatment of the experimental model of multiple sclerosis

Wireless powered optogenetic cell-based implant provides a strategy to deliver subcutaneously therapeutic proteins. Immortalize Human Mesenchymal Stem Cells (hMSC-TERT) expressing the bacteriophytochrome diguanylate cyclase (DGCL) were validated for optogenetic controlled interferon-β delivery (Opto...

Descripción completa

Detalles Bibliográficos
Autores principales: Audouard, Emilie, Michel, Fanny, Pierroz, Vanessa, Kim, Taeuk, Rousselot, Lisa, Gillet-Legrand, Béatrix, Dufayet-Chauffaut, Gaëlle, Buchmann, Peter, Florea, Michael, Khel, Alexander, Altynbekova, Kamilya, Delgaldo, Claudia, Escudero, Encarna, Soler, Alejandra Ben Aissa, Cartier, Nathalie, Piguet, Francoise, Folcher, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science Publishers 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733677/
https://www.ncbi.nlm.nih.gov/pubmed/36370877
http://dx.doi.org/10.1016/j.jconrel.2022.11.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733677/
https://www.ncbi.nlm.nih.gov/pubmed/36370877
http://dx.doi.org/10.1016/j.jconrel.2022.11.008

Ejemplares similares